[Immunosuppression in kidney transplantation].
Fiche publication
Date publication
avril 2011
Journal
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BITTARD Hugues, Pr KLEINCLAUSS François
Tous les auteurs :
Balssa L, Bittard H, Kleinclauss F,
Lien Pubmed
Résumé
These last years, major progress in renal transplantation were observed, especially in immunosuppression with new drugs available. In the first part of this paper, immunological process of allogenic response is described. Then, the different classes of immunosuppressive drugs, their potential associations and new trends in immunosuppression are presented.
Mots clés
Abatacept, Anti-Inflammatory Agents, therapeutic use, Antibodies, Monoclonal, therapeutic use, Antibodies, Monoclonal, Humanized, Antilymphocyte Serum, therapeutic use, Calcineurin Inhibitors, Humans, IMP Dehydrogenase, antagonists & inhibitors, Immunoconjugates, therapeutic use, Immunoglobulin G, therapeutic use, Immunosuppression, Immunosuppressive Agents, therapeutic use, Kidney Transplantation, Recombinant Fusion Proteins, therapeutic use, TOR Serine-Threonine Kinases, antagonists & inhibitors
Référence
Prog. Urol.. 2011 Apr;21(4):250-3